Petros Pharmaceuticals Inc (PTPI)
0.6354
+0.05
(+8.54%)
USD |
NASDAQ |
May 31, 16:00
0.6643
+0.03
(+4.55%)
Pre-Market: 20:00
Petros Pharmaceuticals Gross Profit (TTM): 3.281M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.281M |
| December 31, 2023 | 4.191M |
| September 30, 2023 | 4.630M |
| June 30, 2023 | 1.620M |
| March 31, 2023 | 3.677M |
| December 31, 2022 | 3.703M |
| September 30, 2022 | 2.675M |
| Date | Value |
|---|---|
| June 30, 2022 | 6.245M |
| March 31, 2022 | 4.772M |
| December 31, 2021 | 6.212M |
| September 30, 2021 | 8.511M |
| June 30, 2021 | 9.167M |
| March 31, 2021 | 7.937M |
| December 31, 2020 | 5.513M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.620M
Minimum
Jun 2023
9.167M
Maximum
Jun 2021
5.152M
Average
4.701M
Median
Gross Profit (TTM) Benchmarks
| Avalo Therapeutics Inc | 0.796M |
| Imunon Inc | -- |
| iBio Inc | -- |
| Ocugen Inc | -- |
| Gritstone Bio Inc | -- |